QSI

Quantum-Si Inc
7 filings tracked
healthcarebiotechnologySMALL ($300M-2B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Quantum-Si is strategically positioning itself for a generational leap in proteomics with the upcoming launch of its Proteus platform.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

The latest quarterly results reveal a business in distress, characterized by a 69% year-over-year collapse in revenue and a sharp decline in gross margins.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every QSI filing.

Start Free Trial

Synthesis (Verdict & Resolution)

Quantum-Si's Q1 2026 filing presents a classic 'binary' investment profile. The company is currently in a transitional vacuum, where the legacy Platinum platform is losing traction and the next-generation Proteus platform has yet to hit the market. This has resulted in a dramatic short-term decline in revenue and margins, which the company frames as a temporary pause and the bears frame as a fundamental collapse. The ultimate trajectory of the stock depends on the successful execution of the Proteus launch by the end of 2026. With $190.4 million in liquidity, the company has the resources to bridge the gap, but the lack of operational revenue growth puts immense pressure on the technical milestones of the new platform. Investors are essentially betting on whether Proteus can transform the company from a cash-burning R&D shop into a commercial leader in the proteomics space.

Selected Quarter

Core Takeaway

QSI is experiencing a severe revenue contraction as customers wait for the Proteus platform, creating a race between its cash runway and its product roadmap.

Investor Lens

The trade-off is between the high risk of operational failure/dilution and the high reward of a disruptive proteomics platform launch.

Watch Next

Commercial availability and first-shipment data for the Proteus platform by the end of 2026.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.53Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bearishMay 7

Revenue collapsed 69.4% year-over-year due to customer deferrals.

earnings miss
90%
bearishMay 7

Gross margin dropped from 57.7% to 28.7%.

margin compression
70%
neutralMay 7

Company is pivoting focus toward the 2026 Proteus platform launch.

management change
20%
bearishMay 7

Revenue collapsed 69.4% year-over-year due to customer deferrals.

earnings miss
90%
bearishMay 7

Gross margin dropped from 57.7% to 28.7%.

margin compression
70%
neutralMay 7

Company is pivoting focus toward the 2026 Proteus platform launch.

management change
20%
bearishMay 7

Revenue collapsed 69.4% year-over-year due to customer deferrals.

earnings miss
90%
bearishMay 7

Gross margin dropped from 57.7% to 28.7%.

margin compression
70%
neutralMay 7

Company is pivoting focus toward the 2026 Proteus platform launch.

management change
20%
bearishMay 7

Revenue collapsed 69.4% year-over-year due to customer deferrals.

earnings miss
90%
bearishMay 7

Gross margin dropped from 57.7% to 28.7%.

margin compression
70%
neutralMay 7

Company is pivoting focus toward the 2026 Proteus platform launch.

management change
20%
bearishMay 7

Revenue collapsed 69.4% year-over-year due to customer deferrals.

earnings miss
90%
bearishMay 7

Gross margin dropped from 57.7% to 28.7%.

margin compression
70%
neutralMay 7

Company is pivoting focus toward the 2026 Proteus platform launch.

management change
20%
bearishMay 7

Revenue collapsed 69.4% year-over-year due to customer deferrals.

earnings miss
90%
bearishMay 7

Gross margin dropped from 57.7% to 28.7%.

margin compression
70%
neutralMay 7

Company is pivoting focus toward the 2026 Proteus platform launch.

management change
20%
bearishMay 7

Revenue collapsed 69.4% year-over-year due to customer deferrals.

earnings miss
90%
bearishMay 7

Gross margin dropped from 57.7% to 28.7%.

margin compression
70%
neutralMay 7

Company is pivoting focus toward the 2026 Proteus platform launch.

management change
20%

Filing History

10-QMay 7, 2026
Expand Sequence

Quantum-Si's Q1 2026 filing presents a classic 'binary' investment profile. The company is currently in a transitional vacuum, where the legacy Platinum platform is losing traction and the next-generation Proteus platform has yet to hit the market. This has resulted in a dramatic short-term decline in revenue and margins, which the company frames as a temporary pause and the bears frame as a fundamental collapse. The ultimate trajectory of the stock depends on the successful execution of the Proteus launch by the end of 2026. With $190.4 million in liquidity, the company has the resources to bridge the gap, but the lack of operational revenue growth puts immense pressure on the technical milestones of the new platform. Investors are essentially betting on whether Proteus can transform the company from a cash-burning R&D shop into a commercial leader in the proteomics space.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.